Eliminating barriers to DTC advertising for OTCs and natural health products

Kondro, Wayne
May 2006
CMAJ: Canadian Medical Association Journal;5/23/2006, Vol. 174 Issue 11, p1547
Academic Journal
Reports on the proposal of Health Canada to eliminate statutory barriers against direct-to-consumer advertising of the purported health benefits from using natural health products (NHP) and non-prescription drugs to treat serious diseases. Claims of the proposal's proponents on its impact; Discussion on issues governing its regulatory amendments; Coverage of the licensing regime for NHP and non-prescription drugs.


Related Articles

  • DDR on DTC. DICK-RATH, DEBORAH // Medical Marketing & Media;Oct2014, Vol. 49 Issue 10, p11 

    The article discusses issues concerning over-the-counter drugs and direct-to-consumer brands and mentions the case of GlaxoSmithKline's Biotene for the treatment of dry mouth.

  • Shops' DTC disruption roils FDA, Big Pharma. Thomaselli, Rich; Teinowitz, Ira // Advertising Age;4/10/2006, Vol. 77 Issue 15, p16 

    The article reports that the Coalition of Healthcare Communication is asking the U.S. Food and Drug Administration to start over with new rules for the pharmaceutical direct-to-consumer advertising category in 2006. Some drug companies and their trade group, the Pharmaceutical Research and...

  • CHRONOLOGY OF DIRECT-TO-CONSUMER ADVERTISING REGULATION IN THE UNITED STATES. Mogull, Scott A. // AMWA Journal: American Medical Writers Association Journal;2008, Vol. 23 Issue 3, p106 

    Promotion of pharmaceutical drugs to consumers, called direct-to-consumer (DTC) advertising, has increased significantly since 1997, when the US Food and Drug Administration (FDA) reevaluated its regulations of pharmaceutical manufacturers. DTC advertising has been debated in the literature,...

  • DTC is dead/long live DTC. Chase, James // Medical Marketing & Media;Apr2011, Vol. 46 Issue 4, p6 

    An introduction to the journal is presented in which the author discusses the challenges in direct-to-consumer (DTC) drug marketing in the U.S.

  • Should we back DTC in Europe? Pavlou, Fedra // Pharmaceutical Technology Europe;Jan2011, Vol. 23 Issue 1, p6 

    An introduction to the journal is presented in which the editor discusses an article by Nathan Jessop on direct to consumer (DTC) advertising in Europe.

  • THE EFFECT OF DIRECT TO CONSUMER ADVERTISING (DTCA) OF PRESCRIPTION DRUGS ON MARKET SHARE, SALES, CONSUMER WELFARE AND HEALTH BENEFITS. Kalyanara, Gurumurthy; Phelan, John // Academy of Health Care Management Journal;2013, Vol. 9 Issue 1/2, p53 

    The purpose of this paper is to investigate the effects of direct advertising and promotion to consumers (DTCA) in pharmaceutical drugs industry, a relatively new phenomenon as DTCA of these products was prohibited by the Food and Drug Administration (FDA) prior to the late 1980's ....

  • Direct-to-Consumer Advertising – Education or Emotion Promotion? Wolfe, Sidney M. // New England Journal of Medicine;2/14/2002, Vol. 346 Issue 7, p524 

    The article discusses various issues related to direct-to-consumer advertising in medical care in the U.S. It is reported that, direct-to-consumer advertising has changed the nature of the doctor-patient relationship, the patients are now seeking much more medical information and are actively...

  • Language in Health Communication: Limited English Proficiency (LEP) and the Implications of Linguistic Devices in Health Care Advertising. Belisle, Viviana // Conference Papers -- National Communication Association;2007, p1 

    The purpose of this study is to explore linguistic devices (e.g. words, idioms, acronyms, and other figures of speech) used in health-related advertising materials (direct-to-consumer (DTC) prescription advertising and over-the-counter (OTC) labeling) and their influence in the health status of...

  • Waxman says DTC ad ban should be a priority. M. A. // Medical Marketing & Media;Jan2009, Vol. 44 Issue 1, p9 

    The article reports on the significance of direct-to-consumer (DTC) advertising to U.S. Rep. Henry Waxman of the Committee on Energy and Commerce. Waxman notes that the Food and Drug Administration (FDA) should be given power to impose two-year moratoria on consumer advertisements for some new...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics